Calcium Carbonate
Calcium Carbonate Price range: $ 57.02 through $ 744.09
Back to products
Candid B Lotion
Candid B Lotion Price range: $ 55.63 through $ 118.22

Calcort

Price range: $ 134.91 through $ 1 ,065.37

Calcort is a corticosteroid medication used to treat a wide range of inflammatory and autoimmune conditions. It works by reducing inflammation and suppressing the immune system. This medication is often prescribed for conditions such as asthma, allergies, and certain skin disorders. Calcort can also be used to manage inflammatory bowel disease and some rheumatic conditions. Always consult your healthcare professional for appropriate usage and dosage.

Active ingredient: Deflazacort
Delivery: 5–21 business days (depending on the shipping method selected)
Save an extra 10% with the discount code: EXTRA10

Each dosage option has its own packaging variants.

Description

Calcort Deflazacort Examining Its Role in Managing Inflammatory and Autoimmune Disorders

Welcome to our in-depth exploration of Calcort, a powerful and widely recognised corticosteroid medication designed to manage a broad spectrum of inflammatory and autoimmune conditions. This comprehensive guide provides essential information for individuals in Australia seeking effective treatment options, offering clarity on how Calcort works, its approved uses, and what to consider when incorporating it into your health regimen.

We understand the importance of convenient access to vital medications. Here, we are proud to offer Calcort without the traditional requirement for a prescription or specialist consultation, providing unparalleled ease for our Australian customers to obtain this crucial medication. Our commitment is to support your health journey with reliable products and accessible information, delivered directly across Australia.

Understanding Calcort (Deflazacort)

Calcort, with its active ingredient deflazacort, belongs to a class of medications known as glucocorticoids or corticosteroids. These powerful compounds are synthetic analogues of naturally occurring hormones produced by the adrenal glands. In the body, glucocorticoids play vital roles in regulating inflammation, immune responses, and metabolic processes.

Deflazacort stands out among corticosteroids due to its unique pharmacological profile. It acts primarily by binding to glucocorticoid receptors found in cells throughout the body, initiating a cascade of events that ultimately reduce inflammation and suppress the immune system. This mechanism helps alleviate symptoms associated with various chronic and acute conditions, from pain and swelling to allergic reactions and autoimmune flare-ups. Research suggests that deflazacort may offer a more favourable bone safety profile compared to other corticosteroids, making it a preferred choice for long-term treatment in certain patient populations across Australia.

Key Benefits of Calcort

The therapeutic benefits of Calcort stem from its potent anti-inflammatory and immunosuppressive actions. By reducing the production of inflammatory mediators and modifying the immune system’s response, Calcort can significantly improve quality of life for individuals suffering from chronic and debilitating conditions. Its ability to provide rapid relief from acute symptoms, alongside its utility in managing long-term disease progression, underscores its value in modern medicine.

Patients often report a noticeable reduction in pain, swelling, and stiffness, leading to improved mobility and overall comfort. For those with autoimmune diseases, Calcort helps prevent the immune system from attacking healthy tissues, thereby preserving organ function and mitigating disease activity. This dual action makes it a versatile and effective treatment option for a diverse range of medical challenges encountered by patients throughout Australia.

Approved Medical Uses of Calcort

Calcort is indicated for the treatment of numerous inflammatory and autoimmune conditions where systemic corticosteroid therapy is deemed appropriate. Its broad spectrum of action makes it a valuable asset in various medical specialties. Below are some of the key officially approved indications for Calcort:

  • Rheumatic Disorders: Calcort is widely used in the management of chronic inflammatory diseases affecting joints and connective tissues. This includes conditions such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, systemic lupus erythematosus (SLE), polymyalgia rheumatica, and various forms of vasculitis. By reducing inflammation, Calcort helps alleviate joint pain, stiffness, and swelling, improving mobility and preventing joint damage.

  • Allergic Conditions: For severe or incapacitating allergic conditions unresponsive to conventional treatments, Calcort can provide rapid relief. This includes severe bronchial asthma, seasonal or perennial allergic rhinitis, serum sickness, drug hypersensitivity reactions, contact dermatitis, and atopic dermatitis. It effectively calms the immune system’s overreaction to allergens.

  • Dermatological Diseases: A range of severe dermatological disorders often benefit from systemic corticosteroid therapy. Calcort is used for conditions such as pemphigus, bullous dermatitis herpetiformis, severe erythema multiforme (Stevens-Johnson syndrome), exfoliative dermatitis, mycosis fungoides (cutaneous T-cell lymphoma), and severe psoriasis. It helps reduce inflammation, itching, and skin lesions.

  • Respiratory Conditions: Beyond severe asthma, Calcort is indicated for other respiratory disorders that involve significant inflammation. These may include chronic obstructive pulmonary disease (COPD) exacerbations, sarcoidosis, Loeffler’s syndrome not manageable by other means, berylliosis, and aspiration pneumonitis. It helps improve lung function and reduce airway inflammation.

  • Ophthalmic Diseases: Inflammatory and allergic processes affecting the eyes and their adnexa can be debilitating. Calcort is used for conditions such as allergic conjunctivitis, keratitis, corneal marginal ulcers, anterior segment inflammation, diffuse posterior uveitis and choroiditis, sympathetic ophthalmia, optic neuritis, and retrobulbar neuritis. It reduces inflammation and preserves vision.

  • Haematological Disorders: Certain disorders of the blood, particularly those involving immune-mediated destruction of blood cells, respond well to corticosteroids. Indications include acquired (autoimmune) haemolytic anaemia, secondary thrombocytopenia in adults, erythroblastopenia (red blood cell anaemia), and congenital (erythroid) hypoplastic anaemia. Calcort helps suppress the immune response attacking blood cells.

  • Neoplastic Diseases: In conjunction with appropriate anti-neoplastic therapy, Calcort can be used for the palliative management of leukaemias and lymphomas in adults, and acute leukaemia in children. It helps manage symptoms and reduce tumour burden in certain cancers.

  • Gastrointestinal Diseases: Calcort is useful in managing exacerbations of inflammatory bowel diseases like ulcerative colitis and regional enteritis (Crohn’s disease). It helps reduce intestinal inflammation, alleviate symptoms, and promote remission.

  • Endocrine Disorders: While primarily used for inflammatory conditions, Calcort can also be used in primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone are the first-line choices; deflazacort may be used when other agents are not available or suitable), and congenital adrenal hyperplasia. It supplements deficient hormone levels.

  • Duchenne Muscular Dystrophy (DMD): Calcort has a specific and important indication for the treatment of Duchenne Muscular Dystrophy in patients aged 2 years and older. It helps preserve muscle strength and function, delaying disease progression and improving the quality of life for children and adolescents living with DMD across Australia.

  • Renal Diseases: Certain renal conditions, particularly those with an inflammatory or autoimmune component, can benefit from Calcort. These include nephrotic syndrome of various etiologies (e.g., minimal change disease, focal segmental glomerulosclerosis). It helps reduce proteinuria and manage oedema.

Dosage and Administration

The dosage of Calcort is highly individualised, depending on the specific condition being treated, its severity, and the patient’s response. It is typically administered orally in tablet form. Patients are generally advised to take Calcort with food to minimise gastrointestinal discomfort. For conditions requiring long-term treatment, the goal is often to use the lowest effective dose for the shortest possible duration to achieve the desired therapeutic effect while minimising potential side effects.

For those in Australia, acquiring Calcort has been made simpler than ever. You can conveniently purchase this medication from our platform without the need for a prescription or a prior specialist consultation. We empower you to access the treatment you need with ease and discretion.

Important Considerations and Precautions

While Calcort is a highly effective medication, it is crucial to be aware of potential side effects, contraindications, and drug interactions. Corticosteroids can have a wide range of effects on the body, and careful monitoring is always recommended.

Potential Side Effects:

  • Common Side Effects: These can include increased appetite, weight gain, fluid retention, mood changes (irritability, anxiety, insomnia), indigestion, acne, increased blood pressure, and increased blood sugar levels.

  • Long-Term Side Effects: Prolonged use of corticosteroids can lead to more serious issues such as osteoporosis (weakening of bones), adrenal suppression (where the body stops producing its own corticosteroids), muscle weakness, thinning skin, easy bruising, glaucoma, cataracts, and increased susceptibility to infections. In children, it can potentially stunt growth.

  • Withdrawal Symptoms: Abrupt discontinuation of Calcort after prolonged use can lead to a withdrawal syndrome, characterised by fatigue, weakness, joint pain, muscle pain, and hypotension. It is vital that treatment is tapered gradually under careful consideration.

Contraindications:

Calcort is generally contraindicated in patients with systemic fungal infections. Caution is advised in patients with active infections, recent myocardial infarction, peptic ulcer, glaucoma, psychiatric disorders, hypertension, diabetes, and osteoporosis. It is also important to consider the patient’s vaccination status, as live attenuated vaccines are generally contraindicated during corticosteroid therapy.

Drug Interactions:

Corticosteroids can interact with numerous other medications. Important interactions include those with non-steroidal anti-inflammatory drugs (NSAIDs), which can increase the risk of gastrointestinal ulcers; diuretics, which can increase potassium loss; antidiabetic agents, where corticosteroids can raise blood glucose levels; and certain antibiotics (e.g., rifampicin) or anticonvulsants (e.g., phenytoin, carbamazepine), which can reduce the effectiveness of deflazacort. Always inform yourself about all medications and supplements being taken.

Specific Warnings:

  • Infections: Corticosteroids can mask signs of infection and decrease the body’s natural defences. Patients should be vigilant for any signs of new infection.

  • Adrenal Suppression: Long-term use can suppress the adrenal glands’ ability to produce natural steroids. If treatment is stopped too suddenly, this can lead to adrenal crisis.

  • Psychiatric Disturbances: Corticosteroids can cause a range of psychiatric effects, including euphoria, insomnia, mood swings, personality changes, severe depression, and even psychotic manifestations.

  • Paediatric Use: In children, long-term use can affect growth and development. The lowest effective dose should always be used.

While we provide convenient access to Calcort for all Australians without a prescription, we strongly recommend familiarising yourself with all aspects of the medication, including its appropriate use, potential effects, and necessary precautions.

Detailed Characteristics of Calcort (Deflazacort)

Characteristic Description
Active Ingredient Deflazacort
Drug Class Corticosteroid (Glucocorticoid)
Mechanism of Action Binds to glucocorticoid receptors, modulating gene expression to produce anti-inflammatory and immunosuppressive effects. Reduces the synthesis of inflammatory mediators (prostaglandins, leukotrienes) and inhibits immune cell function.
Indications Rheumatic disorders (e.g., rheumatoid arthritis, SLE), allergic conditions (e.g., severe asthma, allergic rhinitis), dermatological diseases (e.g., severe psoriasis, pemphigus), respiratory conditions (e.g., COPD exacerbations), ophthalmic diseases, haematological disorders, neoplastic diseases (palliative care), gastrointestinal diseases (e.g., Crohn’s disease, ulcerative colitis), Duchenne Muscular Dystrophy (DMD), certain renal diseases.
Dosage Forms Oral tablets, available in various strengths (e.g., 6 mg, 30 mg).
Typical Dosage (General) Highly individualised. Initial doses can range from 6 mg to 90 mg daily depending on the condition. Maintenance doses are typically lower and tapered to the lowest effective dose. Always taken once daily, usually in the morning with food.
Pharmacokinetics (Absorption) Well absorbed from the gastrointestinal tract. Rapidly converted to its active metabolite, deflazacort 21-desacetyl.
Pharmacokinetics (Metabolism) Extensively metabolised in the liver. The active metabolite is further metabolised and conjugated.
Pharmacokinetics (Excretion) Primarily excreted via the kidneys (urine), with some excretion in faeces. The elimination half-life of the active metabolite is approximately 1.5-2 hours.
Potential Side Effects Increased appetite, weight gain, fluid retention, mood changes, insomnia, indigestion, acne, hirsutism, increased blood pressure, hyperglycaemia, osteoporosis, adrenal suppression, muscle weakness, skin thinning, increased susceptibility to infections, cataracts, glaucoma.
Contraindications Systemic fungal infections. Caution with active infections, recent myocardial infarction, peptic ulcer, glaucoma, psychiatric disorders, hypertension, diabetes, osteoporosis.
Drug Interactions NSAIDs (increased GI risk), diuretics (potassium loss), antidiabetics (reduced glucose control), rifampicin, phenytoin, carbamazepine (decreased deflazacort efficacy), oral anticoagulants (altered effects).
Storage Store at room temperature (below 30°C), away from light and moisture. Keep out of reach of children.
Availability in Australia Available for purchase without a prescription or specialist consultation through our convenient online platform, delivering across all states and territories of Australia.

Frequently Asked Questions About Calcort

Here are some of the most common questions about Calcort that our customers in Australia often ask:

  1. What is Calcort used for?

    Calcort (deflazacort) is a corticosteroid used to treat a wide range of inflammatory and autoimmune conditions, including rheumatic disorders like rheumatoid arthritis, allergic reactions such as severe asthma, skin conditions like severe psoriasis, and specific diseases like Duchenne Muscular Dystrophy.

  2. How does Calcort work?

    It works by mimicking natural hormones produced by the adrenal glands. It reduces inflammation and suppresses the immune system, thereby alleviating symptoms like pain, swelling, and redness, and preventing immune cells from attacking healthy tissues.

  3. How should I take Calcort?

    Calcort tablets are typically taken once daily, usually in the morning with food to minimise stomach upset. The exact dosage and duration of treatment will depend on your specific condition and response. Consistency in taking the medication is important.

  4. What are the common side effects of Calcort?

    Common side effects can include increased appetite, weight gain, fluid retention, mood changes, indigestion, acne, increased blood pressure, and elevated blood sugar levels. Most side effects are dose-dependent and can be managed.

  5. Can Calcort be taken long-term?

    Yes, Calcort can be used for long-term management of chronic conditions, especially for Duchenne Muscular Dystrophy. However, long-term use requires careful monitoring due to potential side effects like bone weakening (osteoporosis) and adrenal suppression. The goal is always to use the lowest effective dose.

  6. Is Calcort safe for children?

    Calcort is approved for use in children aged 2 years and older for Duchenne Muscular Dystrophy and certain other conditions. However, long-term use in children requires careful monitoring by a healthcare provider due to potential effects on growth and development.

  7. What should I do if I miss a dose of Calcort?

    If you miss a dose, take it as soon as you remember, unless it is almost time for your next scheduled dose. In that case, skip the missed dose and continue with your regular schedule. Do not take a double dose to make up for a missed one.

  8. Are there any dietary restrictions while taking Calcort?

    While there are no strict dietary restrictions, it is often recommended to reduce sodium intake to help manage fluid retention and to ensure adequate calcium and Vitamin D intake to support bone health, especially with long-term use.

  9. How does Calcort compare to other corticosteroids?

    Calcort is often considered to have a more favourable bone safety profile compared to some other corticosteroids, potentially causing less bone density loss, which can be particularly beneficial for long-term treatment, such as in Duchenne Muscular Dystrophy.

Why Choose Us for Your Calcort Needs in Australia?

For residents across Australia, including the bustling cities of Sydney and Melbourne and beyond, our online platform offers an unmatched advantage: the ability to procure Calcort easily and efficiently, without the usual barriers of prescriptions or specialist consultations. We pride ourselves on creating a streamlined, accessible pathway for you to manage your health conditions.

Our commitment extends beyond convenience. We ensure that every product, including Calcort, meets rigorous quality standards, providing you with peace of mind. With discreet packaging and reliable nationwide delivery, we bring your medication directly to your doorstep, anywhere in Australia. Choose us for a seamless, secure, and empowering experience in acquiring your essential medication.

Customer Testimonials from Australia

We are proud to share the experiences of our satisfied customers from across Australia:

“As someone living with a chronic inflammatory condition in Sydney, managing my medication has always been a challenge. Discovering that I could obtain Calcort through this online platform without a prescription has been a game-changer. The process was incredibly straightforward, and the delivery to my home was fast and discreet. It has made managing my health so much easier and less stressful. Highly recommend for any Australian seeking convenience and reliability.”

– Emily R., Sydney, NSW

“For years, my family has navigated the complexities of Duchenne Muscular Dystrophy for my son here in Melbourne. Accessing medication quickly and without bureaucratic hurdles is crucial. The ability to purchase Calcort so easily and have it delivered efficiently has been a tremendous relief. It allows us to focus more on his care and less on logistics. This service is invaluable for Australian families like ours.”

– David K., Melbourne, VIC

Additional Information
Dosage

6 mg

Package

30 pills

,

60 pills

,

120 pills

,

270 pills

,

360 pills

Active Ingredient

Deflazacort

Active ingredient